Artemisolide is a typical inhibitor of IκB kinase β targeting cysteine-179 residue and down-regulates NF-κB-dependent TNF-α expression in LPS-activated macrophages

This publication has 22 references indexed in Scilit:

• Etanercept
  Drugs, 2007
• Dual inhibitory effects of furonaphthoquinone compound on enzyme activity and lipopolysaccharide-induced expression of cyclooxygenase-2 in macrophages
  Biochemical and Biophysical Research Communications, 2005
• Inhibitors of the LPS-induced NF-?B activation from
  Phytochemistry, 2004
• Inhibitory action of novel aromatic diamine compound on lipopolysaccharide‐induced nuclear translocation of NF‐κB without affecting IκB degradation
  FEBS Letters, 2004
• Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis
  Blood, 2003
• Novel IKK inhibitors: β-carbolines
  Bioorganic & Medicinal Chemistry Letters, 2003
• Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit
  Experimental & Molecular Medicine, 2003
• BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice
  Journal of Biological Chemistry, 2003
• Essential role of MD-2 in LPS responsiveness and TLR4 distribution
  Nature Immunology, 2002
• Direct Phosphorylation of IκB by IKKα and IKKβ: Discrimination Between Free and NF-κB-Bound Substrate
  Science, 1998